AD inhibited ADAM10 protein expression, but not mRNA expression in H1975 (Figure 1A) and A549 (Figure 1B) lung cancer cell lines, and BT549 breast cancer cell line (Figure 1C) in a dosage-dependent manner. The gene discussed is ADAM10; the disease is lung carcinoma.